1 of 1
Story summary
- The U.S. government announced a 71% discount on Novo Nordisk's Ozempic and Wegovy for Medicare patients, effective in 2027.
- The discounts come from a Biden-era law to lower drug prices, affecting 15 drugs with discounts from 38% to 85%, including Pfizer's Ibrance.
- Novo Nordisk expressed concerns about government price setting and the Inflation Reduction Act's impact on patients.
